BSE Live
Feb 24, 09:46Prev. Close
1732.65
Open Price
1738.70
Bid Price (Qty.)
1698.95 (19)
Offer Price (Qty.)
1701.80 (1)
NSE Live
Feb 24, 09:46Prev. Close
1729.50
Open Price
1729.00
Bid Price (Qty.)
1699.70 (12)
Offer Price (Qty.)
1700.40 (4)
| Balance Sheet of Caplin Point Laboratories (in Rs. Cr.) | Jun 05 | Mar 04 | |
| 15 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 5.09 | 5.09 | |
| Total Share Capital | 5.09 | 5.09 | |
| Reserves and Surplus | -5.47 | -6.10 | |
| Total Reserves and Surplus | -5.47 | -6.10 | |
| Total Shareholders Funds | -0.38 | -1.01 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 0.70 | 0.70 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 0.70 | 0.70 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 7.02 | 7.02 | |
| Trade Payables | 4.33 | 2.59 | |
| Other Current Liabilities | 0.81 | 0.38 | |
| Short Term Provisions | 0.07 | 0.00 | |
| Total Current Liabilities | 12.23 | 9.99 | |
| Total Capital And Liabilities | 12.55 | 9.68 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 4.31 | 4.07 | |
| Intangible Assets | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 4.31 | 4.07 | |
| Non-Current Investments | 0.03 | 0.03 | |
| Deferred Tax Assets [Net] | 0.13 | 0.13 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.18 | 0.00 | |
| Total Non-Current Assets | 4.64 | 4.22 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 2.24 | 0.85 | |
| Trade Receivables | 5.05 | 4.12 | |
| Cash And Cash Equivalents | 0.08 | 0.08 | |
| Short Term Loans And Advances | 0.53 | 0.40 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 7.91 | 5.46 | |
| Total Assets | 12.55 | 9.68 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 0.69 | 0.69 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | -- | -- | |
| Other Earnings | -- | -- | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | -- | -- | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | 0.03 | 0.03 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
10.02.2026
Caplin Labs Consolidated December 2025 Net Sales at Rs 542.77 crore, up 10.1% Y-o-Y
09.02.2026
Caplin Labs Standalone December 2025 Net Sales at Rs 189.22 crore, up 2.15% Y-o-Y
12.11.2025
Caplin Labs Standalone September 2025 Net Sales at Rs 175.18 crore, down 15.75% Y-o-Y
05.11.2025
Caplin Labs Consolidated September 2025 Net Sales at Rs 534.04 crore, up 10.54% Y-o-Y